Investigation of Complement Activation Product C4d as a Diagnostic and Prognostic Biomarker for Lung Cancer-Reference-Cited by-同舟云学术

Investigation of Complement Activation Product C4d as a Diagnostic and Prognostic Biomarker for Lung Cancer

Published:2013-08-12 Issue:18 Volume:105 Page:1385-1393
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Ajona Daniel,Pajares María J.,Corrales Leticia,Perez-Gracia Jose L.,Agorreta Jackeline,Lozano Maria D.,Torre Wenceslao,Massion Pierre P.,de-Torres Juan P.,Jantus-Lewintre Eloisa,Camps Carlos,Zulueta Javier J.,Montuenga Luis M.,Pio Ruben

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/105/18/1385/17312510/djt205.pdf

Reference30 articles.

1. Cancer statistics;Siegel;CA Cancer J Clin,2013

2. Reduced lung-cancer mortality with low-dose computed tomographic screening;Aberle;N Engl J Med,2011

3. The state of molecular biomarkers for the early detection of lung cancer;Hassanein;Cancer Prev Res (Phila),2012

4. Immune response as a biomarker for cancer detection and a lot more;Finn;N Engl J Med,2005

5. Immunotherapy for non-small cell lung cancer: novel approaches to improve patient outcome;Shepherd;J Thorac Oncol,2011

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Contribution of the membrane-bound complement regulatory proteins CD46 and CD55 in phases of acute lymphocytic leukemia (ALL) and acute myelogenous leukemia (AML);2024-07-30

2. Complement protein expression changes in various conditions of breast cancer: in-silico analyses—experimental research;Annals of Medicine & Surgery;2024-07-17

3. The complement system as a target in cancer immunotherapy;European Journal of Immunology;2024-07-12

4. Elevated expression of complement factor I in lung cancer cells associates with shorter survival–Potentially via non-canonical mechanism;Translational Research;2024-07

5. Comprehensive proteomic profiling of lung adenocarcinoma: development and validation of an innovative prognostic model;Translational Cancer Research;2024-05